Role of peroxisome proliferator activated receptor-gamma in bacillus calmette-Guérin bladder cancer therapy

Journal of Urology

Volumn 188, Issue 6, 2012, Pages 2384-2390

  Langle, Yanina ^a   Lodillinsky, Catalina ^a,b   Belgorosky, Denise ^a   Sandes, Eduardo Omar ^a   Eiján, Ana María ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUT CURIE   (France)

Author keywords

BCG vaccine; PPAR gamma; regeneration; urinary bladder; urinary bladder neoplasms

Indexed keywords

15 D PGJ2; BADGE; BCG VACCINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER INHIBITION; CONTROLLED STUDY; FIBROBLAST; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ADMINISTRATION, INTRAVESICAL; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED STRAINS; MYCOBACTERIUM BOVIS; PEROXISOMES; PPAR GAMMA; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; THIAZOLIDINEDIONES; TUMOR BURDEN; URINARY BLADDER NEOPLASMS;

EID: 84869079212     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.07.109     Document Type: Article

References (29)

1. R.T. Greenlee, M.B. Hill-Harmon, T. Murray Cancer statistics, 2001 CA Cancer J Clin 51 2001 15
2. F. de Braud, M. Maffezzini, V. Vitale Bladder cancer Crit Rev Oncol Hematol 41 2002 89
3. A. Jemal, R. Siegel, E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
4. G. Sauter, F. Algaba, M.B. Amin Tumours of the urinary system J.I. Epstein, J.N. Eble, I. Sesterhenn, World Health Organization Classification of Tumours Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs 2004 IARC Press Lyon 89 157
5. J. Riemensberger, A. Bohle, S. Brandau IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer Clin Exp Immunol 127 2002 20
6. H. Suttmann, J. Riemensberger, G. Bentien Neutrophil granulocytes are required for effective bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses Cancer Res 66 2006 8250
7. E. Sandes, C. Lodillinsky, R. Cwirenbaum Cathepsin B is involved in the apoptosis intrinsic pathway induced by bacillus Calmette-Guerin in transitional cancer cell lines Int J Mol Med 20 2007 823
8. V. Alvarez, C. Lodillinsky, S. Umerez Inhibition of bacillus Calmette-Guerin-induced nitric oxide in bladder tumor cells may improve BCG treatment Int J Mol Med 16 2005 565
9. C. Lodillinsky, Y. Langle, A. Guionet Bacillus Calmette Guerin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model PLoS One 5 2010 e13571
10. T. Lemberger, B. Desvergne, W. Wahli Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology Annu Rev Cell Dev Biol 12 1996 335
11. B.M. Forman, P. Tontonoz, J. Chen 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma Cell 83 1995 803
12. T. Wang, J. Xu, X. Yu Peroxisome proliferator-activated receptor gamma in malignant diseases Crit Rev Oncol Hematol 58 2006 1
13. K. Yoshida, Y. Hirose, T. Tanaka Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide Cancer Sci 94 2003 365
14. M. Matsuyama, R. Yoshimura A novel approach to anticancer therapies: peroxisome proliferator activator-receptor-gamma as a new target therapy in the treatment of human urological cancer Endocr Metab Immune Disord Drug Targets 9 2009 76
15. M.L. Plissonnier, S. Fauconnet, H. Bittard Insights on distinct pathways of thiazolidinediones (PPARgamma ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells Int J Cancer 127 2010 1769
16. K.I. Nakashiro, Y. Hayashi, A. Kita Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells Am J Pathol 159 2001 591
17. L. Possati, R. Rocchetti, S. Talevi The role of peroxisome proliferator-activated receptor gamma in bladder cancer in relation to angiogenesis and progression Gen Pharmacol 35 2000 269
18. C. Lodillinsky, M.S. Umerez, M.A. Jasnis Bacillus Calmette-Guerin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells Int J Mol Med 17 2006 269
19. T. Inamoto, H. Azuma, T. Ubai Association of PPAR- gamma with BCG immunotherapy Med Hypotheses 72 2009 231
20. M.I. Diaz Bessone, D.E. Berardi, P.B. Campodonico Involvement of PKC delta (PKCdelta) in the resistance against different doxorubicin analogs Breast Cancer Res Treat 126 2011 577
21. A.J. Urtreger, V.C. Grossoni, K.B. Falbo Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells Mol Carcinog 42 2005 29
22. T. Dworzanski, K. Celinski, A. Korolczuk Influence of the peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats J Physiol Pharmacol 61 2010 683
23. K. Jung, A. Tanaka, H. Fujita Peroxisome proliferator-activated receptor gamma-mediated suppression of dendritic cell function prevents the onset of atopic dermatitis in NC/Tnd mice J Allergy Clin Immunol 127 2011 420
24. T. Rampino, A. Ranghino, C. Guidetti Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes Transpl Immunol 18 2007 32
25. G. Wang, B. Qi, H. Zheng (Z)-5-(4-Methoxybenzylidene)thiazolidine-2,4- dione, a novel readily available and orally active glitazone, attenuates the bleomycin-induced pulmonary fibrosis in vivo Biol Pharm Bull 34 2011 219
26. X.M. Wang, D.F. Chen Effects of rosiglitazone on Kruppul-like factor 6 (KLF6) signaling in the livers of rats with nonalcoholic fatty liver fibrosis Zhonghua Gan Zang Bing Za Zhi 15 2007 649
27. Q. Lin, L.P. Fang, W.W. Zhou Rosiglitazone inhibits migration, proliferation, and phenotypic differentiation in cultured human lung fibroblasts Exp Lung Res 36 2010 120
28. G.Y. Zhang, T. Cheng, M.H. Zheng Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts J Plast Reconstr Aesthet Surg 63 2010 1209
29. W. Kassouf, S. Chintharlapalli, M. Abdelrahim Inhibition of bladder tumor growth by 1,1-bis(3′-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists Cancer Res 66 2006 412